Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial
- 1 June 2014
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 383 (9936), 2232-2237
- https://doi.org/10.1016/s0140-6736(13)62709-9
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Usefulness of High-Dose Intravenous Human Immunoglobulins Treatment for Refractory Recurrent PericarditisThe American Journal of Cardiology, 2013
- A Randomized Trial of Colchicine for Acute PericarditisThe New England Journal of Medicine, 2013
- Pericardiectomy vs Medical Management in Patients With Relapsing PericarditisMayo Clinic Proceedings, 2012
- Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra)International Journal of Cardiology, 2012
- Treatment of recurrent pericarditisExpert Review of Cardiovascular Therapy, 2012
- Colchicine for Recurrent Pericarditis (CORP)Annals of Internal Medicine, 2011
- Azathioprine in isolated recurrent pericarditis: A single centre experienceInternational Journal of Cardiology, 2011
- Pericardial DiseaseCirculation, 2006
- Colchicine as First-Choice Therapy for Recurrent PericarditisArchives of Internal Medicine, 2005
- Pericardial diseasesCurrent Treatment Options in Cardiovascular Medicine, 2002